Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo

By
Peter Fedichev, Quantum CTO
– August 9, 2011Posted in: docking, drug design, flue, influenza, publications

The manuscript entitled “” by the Quantum Team has been accepted to PLoS Currents Influenza. The reference:

Fedichev, Peter; Timakhov, Roman; Pyrkov, Tim; Getmantsev, Evgeny; Vinnik, Andrey. Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo [Internet]. Version 206. PLoS Currents: Influenza. 2011 Jul 11 [revised 2011 Aug 7]. Available from: http://knol.google.com/k/peter-fedichev/structure-based-drug-design-of-a-new/1nsjcj02vqpk8/1.

Share

Related posts:

  1. Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
  2. Quantum Discovery Services
  3. Beefing up the pipeline: new leads against influenza virus identified
  4. From binding data to pharmacokinetics: a novel approach to active drug absorbtion prediction
  5. Quantum collaborates with Fox Chase Cancer Center on discovery of new small molecules inhibitors in cancer area.

About Peter Fedichev, Quantum CTO

Peter Fedichev, Ph.D., Chief Scientific Officer, co-founder